Lee read a response from Dryships, which said the deal was at "arm's-length."
In the Rising Star segment, Adami touted Geron (GERN), a company that develops treatments for cancer and stem-cell based therapeutics. He said the stock, which closed at $5.32 today, could either go to zero or to $10. His sense is that it will go to $10.
"Check out "'Fast Money' Portfolios of the Week" on Stockpickr every Thursday.